What a year! The future looking bright....
Likely Developments and Overview of Group Strategy
The Company’s upcoming catalysts and strategy are focussed on the following areas:
• Continued acceleration of sales and ARR growth within RAC sector in ANZ, UK, Canada and new
EU opportunities
• Complete FDA studies to lodge for US FDA De Novo clearance in Q4 2023
• Leverage existing US partnerships including Point Click Care, InterSystems and Ethos Labs to
prepare for US market entry in 2024
• Build on existing Home Care and Disability markets
• Enter global hospital market sector with InterSystems partnership
• Commence “direct to parent” sales and marketing for Infant App
The Company will also be completing a technology upgrade in 2023 and applying for ISO 27001
certification following implementation of Information Management Systems and processes.
Happy Friday Punters..
Ann: Financial Report for the year ended 30 June 2023, page-2
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.0¢ |
Change
-0.001(3.23%) |
Mkt cap ! $49.07M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.0¢ | 3.0¢ | $10.07K | 335.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 86700 | 3.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.2¢ | 177592 | 2 |
View Market Depth
| Last trade - 15.59pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
2.9¢ |
Change
-0.001 ( 6.45 %) |
||||
| Open | High | Low | Volume | ||
| 3.0¢ | 3.0¢ | 2.9¢ | 177539 | ||
| Last updated 11.09am 21/05/2024 ? | |||||
| PCK (ASX) Chart |